A detailed history of Janus Henderson Group PLC transactions in Inari Medical, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 25,276 shares of NARI stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,276
Previous 25,276 -0.0%
Holding current value
$1.36 Million
Previous $1.22 Million 14.38%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$37.11 - $50.69 $9,314 - $12,723
-251 Reduced 0.98%
25,276 $1.22 Million
Q1 2024

May 15, 2024

BUY
$40.65 - $65.76 $40 - $65
1 Added 0.0%
25,527 $1.22 Million
Q4 2023

Feb 14, 2024

SELL
$48.3 - $68.06 $137,075 - $193,154
-2,838 Reduced 10.01%
25,526 $1.66 Million
Q3 2023

Nov 14, 2023

BUY
$54.2 - $71.67 $444,927 - $588,339
8,209 Added 40.73%
28,364 $1.86 Million
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $682,995 - $870,777
12,783 Added 173.4%
20,155 $1.24 Million
Q4 2022

Feb 14, 2023

BUY
$61.23 - $83.62 $451,387 - $616,446
7,372 New
7,372 $468,000
Q3 2022

Nov 14, 2022

SELL
$65.58 - $84.69 $61,907 - $79,947
-944 Reduced 11.35%
7,372 $536,000
Q2 2022

Aug 15, 2022

BUY
$52.13 - $93.81 $222,751 - $400,850
4,273 Added 105.69%
8,316 $565,000
Q1 2022

May 16, 2022

SELL
$64.92 - $99.47 $4.35 Million - $6.66 Million
-66,959 Reduced 94.31%
4,043 $366,000
Q4 2021

Feb 14, 2022

BUY
$76.51 - $93.96 $333,889 - $410,041
4,364 Added 6.55%
71,002 $6.48 Million
Q3 2021

Nov 16, 2021

SELL
$71.29 - $95.99 $941,527 - $1.27 Million
-13,207 Reduced 16.54%
66,638 $5.4 Million
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $6.36 Million - $9.17 Million
79,845 New
79,845 $7.45 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.86B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.